v3.26.1
Note 8 - Financial Instruments Fair Value Measurements - Schedule of Fair Value Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Feb. 03, 2026
Dec. 31, 2025
Debt instrument, fair value $ 15,100   $ 11,100
Rights Liability [Member]      
Rights liability - Lucid Diagnostics common stock 321 $ 375  
September 2022 Senior Convertible Note [Member]      
Debt instrument, fair value   $ 11,149 11,100
The 2026 Note [Member]      
Debt instrument, fair value 15,100    
Fair Value, Recurring [Member]      
Investment in Lucid Diagnostics common stock 33,494   34,120
Total assets at fair value 33,494   34,120
Total liabilities at fair value 15,421   11,100
Fair Value, Recurring [Member] | Rights Liability [Member]      
Rights liability - Lucid Diagnostics common stock 321    
Fair Value, Recurring [Member] | September 2022 Senior Convertible Note [Member]      
Debt instrument, fair value     11,100
Fair Value, Recurring [Member] | The 2026 Note [Member]      
Debt instrument, fair value 15,100    
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]      
Investment in Lucid Diagnostics common stock 33,494   34,120
Total assets at fair value 33,494   34,120
Total liabilities at fair value 321   0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Rights Liability [Member]      
Rights liability - Lucid Diagnostics common stock 321    
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | September 2022 Senior Convertible Note [Member]      
Debt instrument, fair value     0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | The 2026 Note [Member]      
Debt instrument, fair value 0    
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]      
Investment in Lucid Diagnostics common stock 0   0
Total assets at fair value 0   0
Total liabilities at fair value 0   0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Rights Liability [Member]      
Rights liability - Lucid Diagnostics common stock 0    
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | September 2022 Senior Convertible Note [Member]      
Debt instrument, fair value     0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | The 2026 Note [Member]      
Debt instrument, fair value 0    
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]      
Investment in Lucid Diagnostics common stock 0   0
Total assets at fair value 0   0
Total liabilities at fair value 15,100   11,100
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Rights Liability [Member]      
Rights liability - Lucid Diagnostics common stock 0    
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | September 2022 Senior Convertible Note [Member]      
Debt instrument, fair value     $ 11,100
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | The 2026 Note [Member]      
Debt instrument, fair value $ 15,100